Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade...

Area of Science:

• Immunology
• Cancer Biology
• Metastasis Research

Background:

• Natural killer (NK) cells are crucial for eliminating circulating tumor cells and preventing metastasis.
• Disseminated tumor cells (DTCs) can evade immune surveillance at metastatic sites.
• Understanding tumor cell evasion mechanisms is vital for developing effective cancer therapies.

Purpose of the Study:

• To investigate how disseminated tumor cells (DTCs) induce NK cell dysfunction in the lung.
• To elucidate the molecular mechanisms by which tumor cells suppress NK cell anti-metastatic activity.
• To explore the therapeutic potential of targeting the identified suppressive pathway.

Main Methods:

• Utilized mouse models of lung metastasis.
• Analyzed prostaglandin E2 (PGE2) secretion by DTCs.
• Investigated NK cell function, gene expression, and cytokine production.
• Examined the role of PGE2 receptors EP2 and EP4 in NK cell dysfunction.
• Correlated findings with human cancer patient data.

Main Results:

• DTCs in the mouse lung secrete PGE2, leading to local NK cell dysfunction.
• PGE2 signaling via EP2 and EP4 receptors reprograms NK cell gene expression, impairing anti-metastatic cytokine production.
• The PGE2-EP2/EP4 axis is implicated in NK cell dysfunction in human metastatic tumors.
• Blocking EP2/EP4 signaling in NK cells restores their function and controls metastatic growth.

Conclusions:

• Metastatic tumor cells exploit the PGE2-EP2/EP4 signaling axis to suppress NK cell anti-metastatic immunity.
• This pathway represents a promising therapeutic target for overcoming immune evasion in metastatic cancer.
• Restoring NK cell function is a viable strategy for controlling metastatic disease.